Calcium phosphate porous pellets as drug delivery systems: Effect of drug carrier composition on drug loading and in vitro release

Journal of the European Ceramic Society

Volumn 32, Issue 11, 2012, Pages 2679-2690

  Baradari, Hiva ^a   Damia, Chantal ^a   Dutreih Colas, Maggy ^a   Laborde, Etienne ^a   Pécout, Nathalie ^a   Champion, Eric ^a   Chulia, Dominique ^a   Viana, Marylène ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

Beta tricalcium phosphate; Drug delivery system; Hydroxyapatite; Ibuprofen; Porous pellets

Indexed keywords

ADSORPTION CAPACITIES; ADSORPTION EQUILIBRIA; ANTI-INFLAMMATORY DRUGS; BETA TRICALCIUM PHOSPHATE; DRUG CARRIER; DRUG DELIVERY SYSTEM; DRUG LOADING; IBUPROFEN; IN-VITRO; PHOSPHATE BONE SUBSTITUTES; PHYSICO-CHEMICALS; POROUS HYDROXYAPATITE; POROUS PELLETS; RELEASE PROPERTY; TARGETED DRUG DELIVERY;

BIOMATERIALS; CALCIUM PHOSPHATE; DRUG DELIVERY; HYDROXYAPATITE; LOADING; PHYSISORPTION;

PELLETIZING;

EID: 84861653774     PISSN: 09552219     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jeurceramsoc.2012.01.018     Document Type: Article

References (45)

1. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clinical Orthopaedics and Related Research 2002, 81-98.
2. Porter J.R., Ruckh T.T., Popat K.C. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnology Progress 2009, 25:1539-1560.
3. Habraken W.J.E.M., Wolke J.G.C., Jansen J.A. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Advanced Drug Delivery Reviews 2007, 59:234-248.
4. Mourino V., Boccaccini A.R. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. Journal of the Royal Society Interface 2010, 7:209-227.
5. Jain A.K., Panchagnula R. Skeletal drug delivery systems. International Journal of Pharmaceutics 2000, 206:1-12.
6. Vallet-Regi M., Balas F., Colilla M., Manzano M. Bioceramics and pharmaceuticals: a remarkable synergy. Solid State Sciences 2007, 9:768-776.
7. Vallet-Regi M. Revisiting ceramics for medical applications. Dalton Transactions 2006, 5211-5220.
8. Daculsi G., Malard O., Goyenvalle E. Efficacy and performance of bone substitute for bone reconstruction in place of allograft and autograft. ITBM-RB 2005, 26:218-222.
9. Queiroz A.C., Santos J.D., Monteiro F.J., Gibson I.R., Knowles J.C. Adsorption and release studies of sodium ampicillin from hydroxyapatite and glass-reinforced hydroxyapatite composites. Biomaterials 2001, 22:1393-1400.
10. Palazzo B., Lafisco M., Laforgia M., Margiotta N., Natile G., Bianchi C.L., et al. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Advanced Functional Materials 2007, 17:2180-2188.
11. Netz D.J.A., Sepulveda P., Pandolfelli V.C., Spadaro A.C.C., Alencastre J.B., Bentley M.V.L.B., et al. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. International Journal of Pharmaceutics 2001, 213:117-125.
12. Yang P., Quan Z., Li C., Kang X., Lian H., Lin J. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier. Biomaterials 2008, 29:4341-4347.
13. Charnay C., Bégu S., Tourné-Péteilh C., Nicole L., Lerner D.A., Devoisselle J.M. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. European Journal of Pharmaceutics and Biopharmaceutics 2004, 57:533-540.
14. Vallet-Regi M., Ràmila A., Del Real R.P., Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chemistry of Materials 2001, 13:308-311.
15. Öner M., Yetiz E., Ay E., Uysal U. Ibuprofen release from porous hydroxyapatite tablets. Ceramics International 2011, 37:2117-2125.
16. Palazzo B., Iafisco M., Laforgia M., Margiotta N., Natile G., Bianchi C.L., et al. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Advanced Functional Materials 2007, 17:2180-2188.
17. Chevalier E., Viana M., Cazalbou S., Chulia D. Validation of a manufacturing process of pellets for bone filling and drug delivery. Journal of Drug Delivery Science and Technology 2008, 18:438-444.
18. Chevalier E., Viana M., Cazalbou S., Makein L., Dubois J., Chulia D. Ibuprofen-loaded calcium phosphate granules: combination of innovative characterization methods to relate mechanical strength to drug location. Acta Biomaterialia 2010, 6:266-274.
19. Baradari H., Damia C., Dutreil-Colas M., Champion E., Chulia D., Viana M. β-TCP porous pellets as an orthopaedic drug delivery system: ibuprofen/carrier physicochemical interactions. Journal of Sience and Technology of Advanced Materials 2011, 12:055008. 10.1088/1468-6996/12/5/055008.
20. Chevalier E., Viana M., Pouget C., Cazalbou S., Champion E., Chulia D. From porous pellets fabrication to drug loading and release: the case of calcium phosphate matrix loaded with ibuprofen. Bioceramics: properties, preparation and applications in follicular lymphoma and other cancer research 2009, Nova Sciences Publishers. M.P. Safford, J.G. Haines (Eds.).
21. Raynaud S., Champion E., Bernache-Assollant D., Thomas P. Calcium phosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation and thermal stability of powders. Biomaterials 2002, 23:1065-1072.
22. Gracin S., Rasmuson A.C. Solubility of phenylacetic acid, p-hydroxyphenylacetic acid, p-aminophenylacetic acid, p-hydroxybenzoic acid, and ibuprofen in pure solvents. Journal of Chemical and Engineering Data 2002, 47:1379-1383.
23. Chevalier E., Viana M., Artaud A., Chomette L., Haddouchi S., Devidts G., et al. Comparison of three dissolution apparatuses for testing calcium phosphate pellets used as ibuprofen delivery systems. AAPS Pharmaceutical Science and Technology 2009, 10:597-605.
24. European pharmacopoeia 2011, Council of Europe, Strasbourg. 7th ed.
25. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences 1963, 52:1145-1149.
26. Hixson A.W., Crowell J.H. Dependence of reaction velocity upon surface and agitation. Industrial and Engineering Chemistry 1931, 23:923-931.
27. Emmett P.H., Brunauer S. The use of low temperature van der Waals adsorption isotherms in determining the surface area of iron synthetic ammonia catalysts. Journal of the American Chemical Society 1937, 59:1553-1564.
28. Viana M., Jouannin P., Pontier C., Chulia D. About pycnometric density measurements. Talanta 2002, 57:583-593.
29. Moorehead W.R., Biggs H.G. 2 Amino 2 methyl 1 propanol as the alkalizing agent in an improved continuous flow cresolphthalein complexone procedure for calcium in serum. Clinical Chemistry 1974, 20:1458-1460.
30. AFNOR, Implants chirurgicaux - Hydroxyapatite Partie 3: analyse chimique et caractérisation de la cristallinité et de la pureté de phase; 2008.
31. Elliott J.C. Structure and chemistry of the apatites and other calcium orthophosphates 1994, Elsevier Science, Amsterdam.
32. Cuscó R., Guitián F., Aza Sd Artús L. Differentiation between hydroxyapatite and β-tricalcium phosphate by means of μ-Raman spectroscopy. Journal of the European Ceramic Society 1998, 18:1301-1305.
33. Raynaud S., Champion E., Bernache-Assollant D. Calcium phosphate apatites with variable Ca/P atomic ratio II. Calcination and sintering. Biomaterials 2002, 23:1073-1080.
34. Benaziz L., Barroug A., Legrouri A., Rey C., Lebugle A. Adsorption of O-phospho-L-serine and L-serine onto poorly crystalline apatite. Journal of Colloid and Interface Science 2001, 238:48-53.
35. Chevalier E., Viana M., Cazalbou S., Chulia D. Comparison of low-shear and high-shear granulation processes: effect on implantable calcium phosphate granule properties. Drug Development and Industrial Pharmacy 2009, 35:1255-1263.
36. Rowe R.C. Binder-substrate interactions in granulation: a theoretical approach based on surface free energy and polarity. International Journal of Pharmaceutics 1989, 52:149-154.
37. Iveson S.M., Litster J.D. Liquid-bound granule impact deformation and coefficient of restitution. Powder Technology 1998, 99:234-242.
38. Litster J.D., Hapgood K.P., Michaels J.N., Sims A., Roberts M., Kameneni S.K., et al. Liquid distribution in wet granulation: dimensionless spray flux. Powder Technology 2001, 114:32-39.
39. Naiya T.K., Bhattacharya A.K., Mandal S., Das S.K. The sorption of lead(II) ions on rice husk ash. Journal of Hazardous Materials 2009, 163:1254-1264.
40. Stahli C., Bohner M., Bashoor-Zadeh M., Doebelin N., Baroud G. Aqueous impregnation of porous beta-tricalcium phosphate scaffolds. Acta Biomaterialia 2010, 6:2760-2772.
41. Hasegawa M., Sudo A., Komlev V.S., Barinov S.M., Uchida A. High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution. Journal of Biomedical Materials Research - Part B: Applied Biomaterials 2004, 70:332-339.
42. Seshima H., Yoshinari M., Takemoto S., Hattori M., Kawada E., Inoue T., et al. Control of bisphosphonate release using hydroxyapatite granules. Journal of Biomedical Materials Research - Part B: Applied Biomaterials 2006, 78:215-221.
43. Gbureck U., Vorndran E., Barralet J.E. Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta Biomaterialia 2008, 4:1480-1486.
44. Nakano T., Thompson J.R., Christopherson R.J., Aherne F.X. Blood flow distribution in hind limb bones and joint cartilage from young growing pigs. Canadian Journal of Veterinary Research 1986, 50:96-100.
45. Gbureck U., Vorndran E., Müller F.A., Barralet J.E. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. Journal of Controlled Release 2007, 122:173-180.